B

Biomed Lublin Wytwornia Surowic i Szczepionek SA
WSE:BML

Watchlist Manager
Biomed Lublin Wytwornia Surowic i Szczepionek SA
WSE:BML
Watchlist
Price: 5.8 PLN 1.67%
Market Cap: 378.5m PLN

Biomed Lublin Wytwornia Surowic i Szczepionek SA
Revenue

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Biomed Lublin Wytwornia Surowic i Szczepionek SA
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
B
Biomed Lublin Wytwornia Surowic i Szczepionek SA
WSE:BML
Revenue
zł50.4m
CAGR 3-Years
9%
CAGR 5-Years
10%
CAGR 10-Years
N/A
M
Mabion SA
WSE:MAB
Revenue
zł14.8m
CAGR 3-Years
-56%
CAGR 5-Years
N/A
CAGR 10-Years
17%
R
Read Gene SA
WSE:RDG
Revenue
zł15.2m
CAGR 3-Years
23%
CAGR 5-Years
19%
CAGR 10-Years
26%
G
Genomed SA
WSE:GEN
Revenue
zł23m
CAGR 3-Years
5%
CAGR 5-Years
3%
CAGR 10-Years
N/A
B
Bioton SA
WSE:BIO
Revenue
zł295.8m
CAGR 3-Years
14%
CAGR 5-Years
10%
CAGR 10-Years
-3%
S
Synthaverse SA
WSE:SVE
Revenue
zł53.8m
CAGR 3-Years
2%
CAGR 5-Years
6%
CAGR 10-Years
4%
No Stocks Found

Biomed Lublin Wytwornia Surowic i Szczepionek SA
Glance View

Market Cap
407.5m PLN
Industry
Biotechnology

Biomed Lublin Wytwornia Surowic i Szczepionek SA engages in the manufacture of pharmaceutical products. The company is headquartered in Lublin, Woj. Lubelskie and currently employs 223 full-time employees. The company went IPO on 2011-07-29.

BML Intrinsic Value
Not Available
B

See Also

What is Biomed Lublin Wytwornia Surowic i Szczepionek SA's Revenue?
Revenue
50.4m PLN

Based on the financial report for Dec 31, 2022, Biomed Lublin Wytwornia Surowic i Szczepionek SA's Revenue amounts to 50.4m PLN.

What is Biomed Lublin Wytwornia Surowic i Szczepionek SA's Revenue growth rate?
Revenue CAGR 5Y
10%

Over the last year, the Revenue growth was 22%. The average annual Revenue growth rates for Biomed Lublin Wytwornia Surowic i Szczepionek SA have been 9% over the past three years , 10% over the past five years .

Back to Top